Life Sciences

Marlborough medical device company Boston Scientific has received U.S. Food and Drug Administration approval for its TheraSphere Y-90 Glass Microspheres cancer treatment.

NyLa Laboratories, a Worcester startup based at Massachusetts Biomedical Initiatives, known more commonly as MBI, has received certification to open a lab for a COVID-19 diagnostic testing, according to a Tuesday announcement.

Holliston biotechnology firm Harvard Bioscience returned to pre-COVID-19 revenue levels in the fourth quarter, but the company’s financial performance was still down overall for the year when compared to 2019.

Marlborough medical device company Hologic has made yet another acquisition, this time picking up Belgium-based diagnostic company Diagenode for $159 million.

Marlborough medical device company Boston Scientific announced Wednesday that it has entered into an agreement to acquire the global surgical business of Lumenis LTD.

The Massachusetts biopharmaceutical industry raised far more investment than ever before in 2020, coinciding with the coronavirus pandemic that shifted an emphasis to potential lifesaving drugs, according to a report released Thursday.

Phio Pharmaceuticals Corp., a publicly-traded biotechnology firm, has closed its previously announced public offering of 2,246,784 shares of common stock, at a purchase price of $3.42 per share.

Marlborough medical device company Boston Scientific reported a net sales decline of $822 million in 2020, with losses across the board accounting for a 7.7% drop from 2019’s sales.

Marlborough medical device company Hologic will soon integrate Google Cloud’s machine learning technologies into its Genius Digital Diagnostics system, which helps doctors screen for cervical cancer, Hologic announced on Monday.

Marlborough medical technology device company Hologic announced on Tuesday a nearly 90% increase in revenue in the first quarter of 2021, resulting in $1.18 billion in gross profit.